Defrancesco-Serruya Engineered Green Growth Brands takeover plan of Aphria: $APHA $GGB

Canadian cannabis company Aphria, run by Irwin Simon, continues to tout the narrative that another cannabis company backed by Ohio mega millionaires, the Schottenstein family, made an unsolicited and hostile take over offer of Aphria this January after the company was exposed for alleged corporate disclosure conflicts and overpaying for cannabis assets that were owned by insiders. The news, announced by Aphria ($APHA) when alleged bad actor Vic Neufeld was still listed as the company CEO, caused a run up on the stock whose value had been sliced in half after two investment funds published a detailed and documented report questioning the company’s leadership. Under Simon’s leadership this theme of another cannabis company making a hostile move against Aphria is repeated in profiles highlighting his work as CEO. But new text messages between Andy Defrancesco and Michael Serruya show the Green Growth Brands offer was engineered and designed by Defrancesco and Serruya because they knew the board was going to kick out their friendly CEO Vic Neufeld after fallout from the short seller report. Instead of a “hostile” takeover it should have been described as back-stop by insiders to halt the massive shareholder exodus that the short seller report and follow on media stories were generating.

Green Growth Brands ($GGB), which now basically operates as a shell company, was originally founded by Canadian entrepreneur/investor Adam Arviv, Joseph Schottenstein, and the former COO of Victoria’s Secret Peter Horvath. Schottenstein co-invested with Andy Defrancesco, Michael Serruya and Barry Honig in a deal to obtain cannabis dispensary licences in Ohio, according to state license application records. The investment partnership was called Schottenstein Aphria III LLC. Arviv is a regular co-investor in deals backed by Serruya and Defrancesco like Therapix ($)TRPX, according to internal documents tracking investors in the stock complied by Laidlaw & Co the broker dealer on the IPO. Therapix announced this week it would reverse merge into a CBD subsidiary of Defrancesco’s Sol Global Investments called Heavenly RX. I have previously reported how Andy Defrancesco recently bought a new double digit million Miami home down the street from the Schottenstien’s Miami home.

Text messages from early February 2019 show Andy Defrancesco writing Michael Serruya upset that Irwin Simon, who was chairman of the board at the time, was talking directly with the Green Growth guys.

Andy writes: Daviau and Irwin are talking now. I told Daviau we would handle it- you & I. Have you had time to think about our conversation?”

“I bounded it off Jay this morning and he was fine with it. We’d prefer…would be best to go on the board if you’d invite him to. Also we would want to announce some kind of working relationship in CBD. We should set a deadline to figure this out and don’t want to waste to much of either of our time on it.

[Daviau is Dan Deviau the CEO of Canadian investment bank and broker dealer Cannaccord Genuity }

Serruya wrote back: “Irwin and others are bushing back on the Schottensteins and board seat”

Andy writes: “What would you suggest then? Sort of blows up our entire idea if we don’t have all the parties in line.

Serruya doesn’t respond.

Then the next day Andy text Serruya: “Irwin is reaching out to Jay? What’s the story. I told Jay you and I are handling it.”

Andy and Mike appear to be negotiating board seats in this text exchange. Keep in mind Serruya is on the board of Aphria but Andy is not. The tone of the conversation also doesn’t seem hostile. Instead it appears to be a manipulation by Mike and Andy with the help of their friend Jay Schottenstein. This assumes of course the deal was for a price Schottenstein would pay.

According to a person familiar with the transaction Cannaccord was hired to make an offer to Aphria so a real transaction was put into play. Adam Arviv of Green Growth Brands has a close working relationship with Cannaccord.

When Irwin Simon officially came on as interim CEO of Aphria he made multiple media appearances saying that the Green Growth Brands offer wasn’t a price Aphria was worth. It appears he ended up shutting down the Defrancesco/Serruya plan and in mid April when the company announced the Green Growth Brands offer was off the table.

The text messages obtained by this reporter don’t give us a complete look at how the end of this takeover plan went down. But what is clear is this is another example of how Andy Defrancesco works with Canadian mega millionaire Michael Serruya to influence and control public companies from behind the scenes to benefit themselves before shareholders.

Did Aphria’s Irwin Simon give Selective Disclosure to investor Michael Serruya? $APHA $LHS

Aphria interim CEO Irwin Simon worked a backroom deal to off load the company’s stake in U.S. cannabis investments with Canadian mega million Michael Serruya before he took over the CEO job at the Canadian marijuana company. According to text messages obtained by this reporter between Serruya and Irwin sent on the morning of Feb 6, 2019, Michael Serruya took the lead in speaking for his family and Andy Defrancesco to negotiate the price and timing of when Aphria ($APHA) would exit its stake in Liberty Health Science ($LHS). In December 2018 the Toronto Stock Exchange, where Aphria was listed, forced the company to divest any stake in U.S. cannabis companies because they sold products that were illegal by federal law. Irwin was Chairman of the board at the time but Aphria was run by Vic Neufeld who had made an investment in a special-purpose private company called DFMMJ Investment Ltd for Aphria. DFMMJ managed cannabis farm Chestnut Hill Tree Farm, which was one of only seven licensed dispensaries of medical cannabis in the state of Florida at the time. Chestnut Hill Tree Farm was bought by Liberty Healthy Science.

DFMMJ Investment was first exposed as being secretly set up as an LLC by Andy Defrancesco when two short sellers published a series of reports about self-dealing and a lack of disclosures at Apheria and Liberty Health Science in December 2018. The reports tanked Aphria’s stock. Serruya is a board member of Aphria. I have previously reported, based on text and emails from Serruya, he was also controlling Liberty Health Science and DFMMJ investments from behind the scenes by placing puppet executives in charge.

Instead of selling Aphria’s stake in $LHS on the open market through a broker dealer, where buyers don’t know who is selling, the text messages show a transaction was being set up to benefit the Serruya family fund and Andy Defrancesco.

At 8:14 am Simon Irwin sent a text inviting Serruya to a hockey game. Irwin’s follow-on text said ” wrong person” but “welcome to come”. 50 minutes latter Michael Serruya responded:

Spoke to family member and Andy.
-They are prepared to leave in place what we agreed to, in the event that the shares are sold within the first 6 months.
-if the shares are sold from 6-12 they would pay aphria 3% of the net gain. ie. if during month 6-12 the shares are sold for $1.72 per share, (profit of $64 million), they would pay aphria $1.92 million)
-Alternatively they would be prepared to pay an additional $.02 per share ($0.74 p/s), and make the entire 6-12 month section go away.

An hour latter Irwin texted Serruya “call me”

Later in the day Michael Serruya texted he tried to call. Then at 7:48 pm Irwin texted Serruya “Hey working on getting done”.

The exchange leaves a lot of open questions. First why wasn’t the CEO of the company, Vic Neufeld, speaking to Serruya. Why was Serruya speaking for Andy Defrancesco who was not an officer/board member of Aphria or considered an insider? Did this arrangement constitute Serruya or Defrancesco getting inside information and did they trade off that? Why wasn’t the people involved in this arrangement disclosed in Aphria’s public filings?

On the face of things this read like Aphria is giving selective disclosure, which is against securities law in Canada and the U.S.

On February 19th Aphria made this announcement about offloading $LHS. The public announcement only mentions “a group of buyers” but doesn’t name Serruya or Defrancesco. In February, the company was on a PR campaign to repair its image of buying inflated cannabis assets in LatAm and Jamaica from companies that benefited Andy Defrancesco, Serruya and their buddies. Irwin Simon officially took over the CEO job after Vic Neufeld was kicked out on February 15, 2019.

This week Aphria announced earnings which showed the company is not turning a profit yet from marijuana operations. They also disclosed Michael Serruya will no longer be on the board. According to people I spoke with who work on Bay Street, Serruya is telling people he resigned from the board. I call B.S. on that and think it’s more likely Irwin finally asked him to leave given my story last month that showed how Serruya worked with the head of Canadian broker dealer Clarus to allegedly get inside info and conduct match trades.

Last month I verifed the text messages were written by Irwin when I called the cell phone and he answered. I told him I had copies of his text with Serruya and began to read them to him so he could comment on their intent. He then hung up on me and didn’t let me finish. I texted him saying we need to finish our conversation as the messages could imply insider trading and other things and he immediately answered “I am not worried as there is no truth to this, this never would happen.” Except he didn’t know which text I had.

Michael Serruya didn’t return an email for comment asking about him leaving the board. In fact, Serruya has never responded to any of my requests for comment. He has aggressively been grilling people on Bay street (or anyone he has worked with) trying to find the source of the people who leaked the texts.

The Globe and Mail this week reported Irwin would be getting a $10 million pay package in stock and cash. “Mr. Simon’s arrangement treats him as an independent contractor, paying him $500,000 annually for the CEO job and $600,000 annually to be chairman”, according to the Globe and Mail.

Aphria is still battling a shareholder securities fraud class action lawsuit that names Andy Defrancesco personally as a defendant along with the former Aphria CEO Vic Neufeld.

Barry Honig Secret profit taking of Short Selling publication ? $OPK $MGTI

A popular fraud busting stock publication owned by Hunter Adam’s family,, allegedly had given an ownership stake to people charged in the SEC’s pump and dump case against Barry Honig in return for an investment in the company. According to documents and communication reviewed by this journalist, written in March 2011, a fund called Contrarian Fund was given a 25% stake in AFB Media which is the registered parent llc for The documents show Barry C. Honig and John Stetson allegedly had ownership in Contrarian Fund. published multiple short selling reports in companies like MGT Capital ($MGTI) and Cool Holdings ($AWSM) in which Barry Honig was also a PIPE Investor in at one point. disclosed it also held short positions in the stocks it was publishing research on.

Hunter Adams who is on the board of is the cousin of Barry Honig according to a person who both men told this to at a lunch meeting. In 2001 Hunter Adams and his brother Gregg Adams where charged criminally on multiple counts of wire fraud and securities fraud for their role in a stock manipulation scheme that was used to raise money for the mob crime family the Gambinos. One of Hunter’s co-defendants in the criminal case is the brother-in-law of Barry Honig; Johnathan Doneson is the husband of Honig’s sister Susan Gayle (Honig) Doneson.

Susan & Johnathan Doneson with brother Barry Honig

In 2010 Hunter did a interview about the start of his publication and the hiring of seasoned business jouranlist Melissa Davis. Davis was an investigative jouranlist for until she said she was laid off and applied for a job with Adams. Hunter Adams said the publication was funded by his wife Suzanne Adams. California corporate registration filings show Hope Adams (believed to be Hunter’s sister) is the original manager of AFB Media. said on its website AFB Media is its parent company. The California registration was then switched to Hunter Adams daughter’s name Sara Adams. In the 2010 interview the company said it wasn’t presently short the stocks they were writing on but they wouldn’t rule out the idea.

Apparently that changed when, according to documents reviewed by this reporter, Barry Honig personally lent $2 million to John Stetson via an LLC John owned with the intent for money to go to Hope Adams. According to a person interviewed by this reporter who had experience working with Honig and was interviewed for the Government investigation against Team Honig, the money was to be used to help start a trading account at a brokerage called Lightspeed. The documents say a fund called Contrarian Fund would own 25% of AFB Media and a member of the Adams family would own the remaining 75%. According to the documents Barry Honig owns 37% of Contrarian Fund. John Stetson is believed to be the manager of Contrarian Fund. The Securities and Exchange Commission accused Barry Honig of hiding over 90% ownership of another fund, called H.S. Contrarian, that was listed in SEC filings as being owned by John Stetson. Honig settled the SEC charges this June and agreed to a penny stock ban of not holding more than a 5% interest.

A review of the twitter feed, and cached stories, along with reports republished at Seeking Alpha, was very active detailing alleged wrong doing in tons of microcap stocks which led to a drop in the price of the stock. Major media publication like Baron’s and Bloomberg sourced reports. Stocks the publication ran short reports on in which Honig also invested are: $RVLT, $MSRT, $MDXG, $HOTR, $AWSM, $MGTI. stated on its website under a section called Public Oath:

Since inception in 2009, The Street Sweeper has alerted the public to hundreds of companies that our research indicates have littered the market with deception, promotions, dilutive shares and shoddy financials that ultimately hurt the little guy.

But the company apparently forgot to mention that Barry Honig and John Stetson were allegedly also profiting from negative research published and the trading profits made by after the reports ran and the stock declined.

A document from March 24, 2011 said:

“profits from operations and trading” for the would be divided as follows: Hope Adams 50%, Barry Honig 37.5%, John Stetson 12.5%.

Journalist Melissa Davis left around 2015. A journalist with little experience writing about securities fraud named Sonya Colberg showed up as taking over the reporting. Colberg had previously reported for Tulsa World. Since the SEC brought their case against Honig in September 2018 slowed down the number of reports it ran. The last tweet on a new short report was in August 2019. The report was on United Health Products ($UEEC) and the company is now suing for defamation. Honig settled the SEC case over the Summer of 2019. Over the last month since this reporter began asking questions about the publication website can’t be reached with a messages saying the site’s bandwidth has been reached. A public records search shows the trademark for was not renewed in 2018. Sonya Colberg and Hunter Adams did not respond directly to an email for comment sent to on September 13,2019.

In 2013 a hedge fund named Lakewood Capital, run by Anthony Bozza, published a statement questioning the relationship between Barry Honig and Hunter Adams. Lakewood had given a presentation at the Robin Hood stock conference about problems they saw in OPKO Health and Honig’s questionable relationship with the company. Honig and Stetson invested in $OPK, which is run by their co-defendant billionaire Philip Frost. Right after the Lakewood presentation ran an out-of-character long report about all the things they thought were wonderful about $OPK. Lakewood also accused Hunter Adams and Barry Honig of being cousins and not disclosing their relationship. According to a person who worked with Honig the Adams family had been given or acquired a ton of stock options in $OPK. The options would be more valuable when the stock went up in price. The Lakewood Capital report is believed to be the first time the The Street got a whiff of how Team Honig operated.

In May 2017, ran a critical article on John McAfee selling assets to MGT Capital accusing the company of being pumped with an expectation of a coming dump. They followed up with another story in August 2017 analyzing questionable investments made by MGT. None of the articles mention that John Stetson and Barry Honig were also investors in MGT, which the SEC complaint showed they also benefited from the quick rise of the stock. MGT’s president Robert Ladd is also a co-defendant in the SEC Honig case and is fighting the charges. Ladd didn’t respond to a request for comment about Honig’s alleged investment in You see while Honig invested in MGT Capital he also got really pissed when Ladd pulled out of a deal that would have given Honig a ton of cheap stock warrants in MGT via an invest in a company called DeamonSaw that MGT was going to buy. And Honig sued Ladd and MGT in 2017 around the time short reports were coming out. Honig eventually dropped the litigation against MGT according to filings in federal court.

The theory among people interviewed by this reporter who have worked with Honig is was used by Honig to help short stocks of the companies he had gotten out of at the top of the pump. (or in the case of $OPKO benefit from long reports) There could be questions on if this would constitute a Reg SHO violation which says investors in PIPE deals can’t also short the stock. The SEC rule was set up because PIPE investors usually cross the Chinese Wall and have access to material non public information of the company they invest in. A PIPE deal is a private investment in a public entity. Based on reporting by this reporter over the last four years it is becoming clear how Honig allegedly made money on every piece of a financial transaction involving publicly traded companies. The government could also be looking at a new set of charges if the Adams family, Honig and Stetson were trading as an undisclosed group of affiliates. I have previously reported the San Francisco DOJ has an open investigation into Team Honig and charges are expected in the near future. The SEC has confirmed the DOJ criminal investigation in court documents filed in federal court.

Yesterday a lawyer from Oakland, California, David Shapiro, who said he represents emailed this reporter saying “Barry Honig or any of his LLCs did not have any ownership in”. This morning after I obtained additional information showing the plan for Contrarian Fund to be used to invest I asked the lawyer if his client wanted to clarify their statement based on very detailed documented evidence. Attorney Shapiro wrote back says ‘the statements you are making are false and could be considered defamatory’. I responded I am running the story and will use this as their on the record comment. Attorney Shapiro does not represent Barry Honig. An additional email was sent to Honig’s AOL email account asking to comment on his relationship with and the alleged profits he received from the short seller reports. Honig did not respond. An email was also sent to John Stetson’s attorney George Conellos at Millbank which was not returned for comment.

Melissa Davis the original editor of could not be reached for comment. I have obtained no evidence or testimony that Davis knew about Honig’s alleged role with Sonya Colberg would not answer questions about what she knows about Honig’s alleged involvement. The last time @sonyacolberg tweeted was August 13,2019. Given the evidence obtained for reporting on this story goes back to 2011 there is no clear line of evidence to how long Honig and Stetson allegedly stayed invested in

Hunter and his brother Gregg Adams were ordered to pay $5 million in restitution and fines in their stock manipulation criminal case from 2001. After the criminal case Hunter Adams was broke, according to a person who worked on the case. Barry Honig is also helping his cousins in their house flipping business. Honig and his cousin Gregg Adams were recently sued over one of the rehab home deals in California state court. Honig owns a company called Three Kings of Queens which corporate records show was tied to the Adams family via Suzanne Adams.

UPDATE: 10-9-19: and it’s reporter Sonya Colberg were sued in Nevada state court yesterday by one of the companies ($UEEC) it recently published a short report on.

Barry Honig Secretly funded Underwriting in his Laidlaw & Co. Deals: $TRPX

Laidlaw & Co. and Barry Honig, a small cap investor charged by regulators for running a long time pump and dump scheme, worked together to fund the underwriting of firm commitment initial public offerings unbeknownst to main street investors in the IPO’s. According to two senior staffers at Laidlaw, the broker dealer’s clearing firm Sterne Agee stopped honoring their back-stop agreement with Laidlaw in 2016 and wouldn’t put up the net capital needed to sell the small cap offerings. New internal documents given to this reporter show one of the Honig led deals Laidlaw sold is Therapix Biosciences Ltd in which Honig also provided the money for underwriting.

Laidlaw began looking for new clearing firms in 2016 but found that only one other clearing firm, Cor Clearing, was interested in their business–and a due diligence fee of $25,000 per deal would be required before Cor would allow Laidlaw to raise money for any company, according to former Laidlaw employee John Marinaccio. So the firm’s executives, Matt Eitner and Jimmy Ahern, hatched a plan to stay with Sterne Agee and ask Barry Honig to put up the 10% needed to fund the underwriting in the IPO’s he was a lead investor in. According to Laidlaw board minutes from March 6, 2017, Either and Ahern held a quorum of just themselves to approve the loan. Honig used an LLC he owned 94% of called HS Contrarian Investments to make the loan. SEC filings for Therapix say Honig’s co-conspirator in the SEC’s securities fraud case, John Stetson, owns and controls the llc but the SEC says in court filings this is a false statement.

Therapix ($TRPX) is a biopharma company started out of Israel who jumped on the medical marijuana bandwagon during the time of the Laidlaw IPO. The offering was sold for $6 per share. Honig’s long time SEC transaction lawyer, Harvey Kesner, was the lawyer for the IPO. Attorney Kesner is currently being sued for malpractice by one of the victim companies in the SEC enforcement case named MabVax.

Harvey Kesner, Jimmy Ahern, Matt Eitner

After the offering was sold in early 2017, Laidlaw then issued an analyst report giving the stock a buy rating with a price target of $18. The stock had two quick run ups and cliff nose drops since the IPO which could be seen as a pump and dump. Therapix reached a high of $8.94 off its IPO in March 2017 and another high in November 2018 of $8.65. The stock is currently trading below $3 and received a formal warning from NASDAQ about being dropped from the exchange because it wasn’t meeting listing requirements.

A review of Laidlaw financials filed with FINRA show they accepted subordinate loans of $6.25 million in 2016 and $3 million in 2017. HS Contrarian wasn’t the only llc used to fund underwriting in Honig backed deals. Honig also had Mark Groussman and his brother Johnathan Honig use their investment companies to fund some deals, according to a Laidlaw employee who saw internal documents related to the transactions.

Matt Eitner responded to a request for comment saying, “Any public offering that Laidlaw engaged in, including any related documents, as an underwriter have been filed and approved by the appropriate regulatory authorities.”

While Eitner at least had the sense to asked FINRA if they could do the subordinate loans, brokers I interviewed who sold the Therapix offering said they were not told Honig was funding the underwriting and was also investing in the deal. This meant that retail investors were also not informed. Honig secured a group of investing buddies to help him out in what appears to be an undisclosed affiliate group. Laidlaw president Matt Eitner told this reporter, “We always make the appreciate disclosures”. But a current FINRA investigation into Either, Ahern, and Laidlaw shows regulators think otherwise.

Team Honig’s involvement in Therapix was first reported by Chris Carey at

According to an internal sales and order tracking document for Therapix written by Laidlaw broker Luke Kottke, the $13.7 million raise was 91% funded by Honig and others he trades with as alleged undisclosed affiliates. The document obtained by this reporter shows the investors are: Michael Serruya/Serruya Private Equity, Adam Arviv, Barry Honig/HS Contrarian, Jonathan Honig (Barry’s brother), John Stetson, John O’Rourke/ATG Capital, John O’Rourke Sr., Corey O’Rourke, Andrew Schwartzberg, Iroquois Capital/Richard Abbe, Robert Prag, Adrian James, Roy Langston, Ed Karr,Jason Theofilos, Sean Posner and others. Honig was also able to get a few board seats out of his investment and put Mark Groussman and Eric So on the board. Groussman is a co-defendant in the SEC pump and dump case and has plead guilty. Eric So is also on the board of Riot Blockchain and believed to be one of Honig’s rent-a-directors. Broker Check records for Eric So show he was fired from RBC for multiple violations of personal trading.
If some of these names are not familiar here is how they are related to Honig deals:

– Schwartzberg also was an investor in the April 2017 private placement for Bioptix that preceded its transformation into RIOT. He also invested in the December 2016 Majesco private placement at the time of the PolarityTE agreement, and was an early investor in Marathon Patent.

– Michael Serruya and Barry Honig co invested in land for cannabis farms and dispensary licenses.

– Adam Arviv also was an investor in the Bioptix and Majesco placements, as Acquisition Group Ltd. He was also was a director of Green Growth Brands, and played a role in its “hostile takeover” for Aphria. Text messages, obtained by this reporter, between Adam and Andy Defrancesco and Michael Serruya show they are friends that plan their investments together.

– “Roy Langston” is Ray Langston (full name Charles Raymond Langston III), a longtime Honig investor who was charged with fraud by the SEC in 2013.

– Adrian James is a stock promoter who also got shares in the Bioptix placement – a Honig led deal.

– Robert Prag is a stock promoter who I reported was recently named in a securities fraud suit filed by Mabvax – one of the victim companies in the SEC’s enforcement case against Team Honig. The lawsuit says Prag was paid to promote Mabvax at the insistence of Barry Honig.

– Ed Karr is the current CEO of US Gold Corp. ($USAU). He’s been involved in a number of Honig companies over the years, including Pershing Gold and Majesco. He was a director of Majesco until December 2016, when it agreed to merge with PolarityTE.

– Jason Theofilos was an investor in Bioptix, through JAD Capital. He also was a director and large shareholder of Coinsquare, a Toronto digital currency exchange into which Riot Blockchain invested millions. He also heads MundoMedia, a Toronto digital advertising company in which Barry Honig, Jonathon Honig, Groussman and O’Rourke were investors.

– Sean Posner is believed to be the son of the late Victor Posner, barred by the SEC for fraudulent activities, and whose brother was the late Steven Posner, who also was barred by the SEC. Both were involved with financial felons Ivan Boesky and Michael Milken.

The internal Laidlaw sales tracking document shows the total book for the IPO sold was for $13,720,992 with only $1.2 million coming from Laidlaw’s main street retail customers. Team Honig funded the rest and as the SEC has described in their securities fraud lawsuit this group fits the pattern of an undisclosed affiliate and would have a controlling ownership of the company which was not disclosed. The only disclosure made was John Stetson had a 5.9% ownership. Given we know now that Stetson doesn’t actually own HS Contrarian that ownership statement is now allegedly false. Records show Stetson only invested $600,000 while HS Contrarian invested $1.2 million in the IPO.

Canadian multi-million Michael Serruya, who I reported this month was involved in an investigation by the OSC that included bad boy investor Andy Defrancesco, invested $1.8 million in Therapix. The documents show he was the largest individual investment in the IPO. There were also stock purchases made in the name of Aphria-Colonial Capital of $1.2 million. It’s unclear who owned this investment from the document but a person familiar with the former Aphria CEO says this is Vic Neufeld and Aphria co-founder Cole Cacciavillani’s account. Serruya had made statements to people who work on Bay Street (Toronto’s version of Wall Street) that he was never involved with Barry Honig’s pump and dump scheme but did make investments in companies Honig invested in on the recommendation of Defrancesco and Honig. Defrancesco and Serruya are not named defendants in the SEC enforcement case against Honig.

The internal Laidlaw documents also show a Honig relationship with a South Florida broker dealer called Delaney Equity Group run by David Delaney. The Broker Dealer was charged criminally last year by the Miami DOJ and FINRA revoked their license this year. Employees I spoke to at Laidlaw told this reporter they were often told to send Honig’s shares to Delaney via his account called the Barry and Renee Honig charitable trust. There has been speculation Honig would use shares held at Delaney Equity to trade against the companies he invested in. This ideal was also mentioned in the SEC lawsuit without naming the broker dealer. With the Therapix IPO there was a million dollar worth of shares issued in Barry’s brother’s name, Johnathan, through Delaney Equity. David Delaney was never charged criminally by the DOJ, it’s unclear if he is working was a witness against team Honig in the DOJ’s parallel criminal investigation looking into years of Honig’s group running pump and dump schemes.

Honig settled with the SEC this summer and was banned from trading in penny stocks but is continuing to litigate the amount of fines and restitution he will pay. Honig awaits to see if he will be charged by the Department of Justice.

I have previously reported Laidlaw is under FINRA investigation and the FBI has opened a case investigating the executives at Laidlaw.

Text messages show Cannabis investors Defrancesco & Serruya allegedly Colluded with Clarus Securities’ Christodoulis in Multiple Stocks

A foreign investor in the cannabis sector published a report this week detailing how Andy Defrancesco and a gang of high net worth investors set up complicated private transactions securing dirt cheap stock in the company Sol Global Investments would reverse merge with to become publicly traded. The report only uses research from the cannabis company’s obscure and often confusing financial statements to show Team Defrancesco getting millions of shares of stock at a discount 25 times less than what it was sold to unsuspecting retail investors. To execute the scheme they had to have had help from gatekeepers. New emails and text message obtained by this publication now show enablers such as lawyers, friendly CEO’s, the head of a broker dealer, and a mega millionaire investor collude together to allegedly manipulate multiple stocks, like Sol Global, over the last decade, rape retail investors through self dealing transactions, and possibly trade on inside information.

The investor report goes back to September 2016 when a highly diluted private placement took place with an investment into a cash poor company called Kitrinor Metals led by a “finder” who happen to get 8 percent of the gross proceeds of the offering and discounted warrants. The report says:

While past shareholders paid over $1.2/share, participants of the private placement got them for $0.05 (Common Shares) and $0.10(Warrants) respectively-That’s25x higher.

The author of the report reached out to Sol Global’s current CEO Brady Cobb and ask him to identify the unnamed players in the public filings. Cobb said he answered some of the author’s questions on twitter but Cobb wouldn’t say who the finder was when I wrote him for comment.

According to a person who worked with Defrancesco along with a review of deal documents and press releases that finder is none other than Andy Defrancesco. This means before he became chairman and CIO of Sol Global he was already racking in thousands of dollars to set up a Multi State Operator cannabis company that he knew he was going to control as a public company down the road. Defrancesco became CIO in the fall of 2018 and as I reported early this month was forced out as an officer of the company from negative press. It’s unclear how much of the millions in cheap warrants and stock Defrancesco has retained through multiple llc’s and family members names.

Defrancesco uses some of the discounted warrants and stock by giving them to a trader named Andrew Rudensky. I reported this month Rudensky was named in an OSC investigation and was banned as a broker for two years by Canadian regulator IIROC. Rudensky effectually now works for Defrancesco. On Monday there was an opening run on Sol Global stock ahead of the investors report. The company knew the report was coming out. The stock, which trades on the Canadian Stock Exchange and the OTC Markets, flew up by ten cents without a lot of volume of trading. $ $Solcf are the tickers for the stock which has been trading under one dollar. According to a person who worked with Defrancesco, he uses Rudensky to effect trading orders to get the stock up to counter negative press or so Defrancesco and friends can dump their shares.

The investor report goes on to detail other private placements that benefited team Defrancesco at the expense of retail holders. We also see another one of Defrancesco’s enablers helping raise money for the creation of Sol Global (formerly named Scythian Biosciences) which is Clarus Securities run by Jimmy Christodoulis.

Christodoulis, another Canadian, is often rumored to be very close friends with Andy Defrancesco. The broker dealer he runs is a sponsor of Andy’s son’s professional race car team. And now based on a series of text messages I received between Christodoulis, Andy Defrancesco, and mega millionaire investor Michael Serruya we know they are more than just drinking buddies.

Michael Serruya was a major investor in an LLC that Sol Global bought with cash and stock called CannCure, according to a copy of Serruya’s internal documents at his private equity firm, obtained by this reporter, the initial investment was for $22 million. When Defrancesco and Serruya make private investments in the form of debt that turns into common stock there are usually some restrictions to when the stock can be traded. It’s called restricted stock. If they want to get out of the stock earlier than the deal documents or the law requires they would need a lawyer to write a false opinion letter or a broker dealer willing to trade their restricted stock for free trading stock. Both moves are illegal.

According to a group text message from April 26 2018 at 9:37pm, obtained by this reporter, Jimmy Christodoulis, allegedly does this for Defrancesco and Serruya.

Andy Defrancesco texted to Michael Serruya and Jim Christodoulis:

Mike-Jimmy here also
Announce increase from $10 to $20m raise
Clarus 100% manager
They swap FT for restricted for us

Jim Christodoulis texted back:


FT stands for free trading shares.

Christodoulis and Serruya were made aware of the content of the text messages I obtained yesterday and would not comment on if they colluded to work with Clarus as a broker dealer to raise money in return for swapping out stock. A move that would be viewed as a securities violation by regulators if they can prove the swap stock was made. The text chain doesn’t say which stock they planed to do this with.

I have obtained over a dozen text messages with conversations on separate dates between Michael Serruya and the men he alleged colludes with. A lot of the messages are Serruya complaining to Jimmy and Andy about the price of Aphria and Liberty Health Sciences. Serruya is on the board of Aphria ($APHA) and was an initial investor in Liberty Health Sciences ($LHS). The phone numbers are confirmed as belonging to each man.

On November 8th at 9:48am Serruya text Christodoulis:

If I could convince the aph Board to fire Vic, and get real bankers, the stock will hit $10 today

Christodoulis responds:

Why the fuck are you offering 110k of LHS put loud on the board well below where I’ve already traded 500k shares today

Defrancesco chimes in

Fucking retards

Serruya responds to Christodoulis and Defrancesco with more F-bombs and then writes:

Weeds up $1.10 and aph is up all of 21 pennies.
I hope the 2 of you, and Vic, get struck by Lightening

The foul mouth locker room talks is central in most of the text messages with the men calling each other faggots, pathetic and morons and then pat each other on the back when one of the stocks they invest does well. The Vic Serruya is referring to is Vic Neufeld, the former CEO of Aphria that was forced to step down this year. Serruya’s nickname for Defrancesco is “self absorbed 3 foot man” and for Christodoulis it’s “Greek angry bastard”. Defrancesco responded in an email to this reporter that he is also called “little man or five foot nothing” by Serruya. Defrancesco says he is 5 foot 4 1/2 inches tall (But apparently he has lied on his drivers licenses because a public records search for over a dozen Broward County, Fla. traffic infractions says he is 5 feet 6 inches).

On October 17 Serruya texted Christodoulis and Defrancesco:

I’m nominating you two faggots for bankers of the year award.
you guys are fucken legends.

The text message exchanges also show Christodoulis talking about a private raise for MedMen and estimating how well it will sell. Serruya also ask Christodoulis for information about a stock called MedReLeaf and Defrancesco chimes in that Serruya needs the info so he can short the stock. MedReLeaf was acquired by Aurora in May 2018.

On October 3rd Christodoulis writes Serruya with Defrancesco included in the text message chain:

Good Morning Michael,
I see you out there on the LHS this am. If it helps I can buy 1mm @ 85c.
Let me know. Thx

Serruya writes back that he is wrong it’s not him in the trade

Christodoulis responds:

I didn’t think it was you but wanted to make sure I let you know just in case
Hope you’re well

The language in this text could be construed as Christodoulis, the head of a large Canadian broker dealer, willing to effect a wash trade for Serruya to help create liquidity in the stock. Wash trades are a securities violation.

Jimmy Christodoulis and Michael Serruya did not respond to my emails for a request for comment on the content of the text message. Defrancesco would not answer questions sent in email except to respond with another disparaging personal message about this reporter and then sent a second email saying No Comment. According to more than one person who has worked with them on Bay St, the men have been calling in people who work with or have worked with them to have their communication equipment checked to see if they are communicating with this reporter.

Update 9.21.19: Andy Defrancesco says he is 5.4 1/2 inches I previously reported he is 4 foot 8 inches.

Editors Note: Given the understanding and past experience that Serruya or Defrancesco threatens people who speak with journalist I am not publishing the actual text messages I have obtained or disclosing sources that sent them. They have been verified with a third party consultant to confirm that are authentic communications. The investor who wrote the analysis quoted in this story has said publicly he did not end up buying Sol Global stock and was not paid to write the analysis. This is the second story in a series of reporting on the internal documents and communications I received. is funded by reader donations please consider supporting independent journalism with a donation today.

Canadian Regulator Demanded Michael Serruya turn over Defrancesco Communications: $SCU.TO

Cannabis Investor and mega Canadian millionaire Michael Serruya was hauled into the Ontario Securities Commission office last year after the Canadian regulator subpoenaed him for an on record interview and demand document production. The securities investigation centered on a Mississauga, Ontario-based coffee shop chain called Les cafés Second Cup. Michael and his brother Aaron Serruya are board members of the company which trades on the Toronto Stock Exchange under $SCU,TO and the OTC Markets. The subpoena demanded communications from Andy Defrancesco and his wife Catherine along with a broker Defrancesco worked with named Andrew Rudensky.

Second Cup saw two suspect spikes in volume and price in the first half of 2018 with the stock going up and down by at least a dollar in a short amount of time. The regulator’s order was issued on June 13, 2018 and was addressed to Michael Serruya at his Yogen Fruz Ontario, Canada address. The Serruya family made triple digit millions developing the frozen yogurt brand and is estimated to have a net worth of over half a billion. Serruya made news this year when he was tied to Defrancesco in self dealing cannabis farm acquisitions with Aphria ($APHA).

The subpoena issued, under section 11(1)(a) of the Securities Act, asked Serruya for: all of his brokerage accounts from 2017/2018 that he had control over, all email address, all make and models of his cell phones, and was told to not delete any text, emails, instant messages or other recorded communication with the Defrancesco and Andrew Rudensky. This publication has seen a copy of the official OSC demand letter.

The OSC letter says, Serruya had to show up to the OSC office with the documents on July 6th 2018 to give evidence under oath. The OSC investigator was Stuart Mills. According to a person familiar with the situation he also had to turn over his communication devices.

The regulator warned Serruya he had to keep the investigation confidential and not tell the people named in the subpoena.

The investigation is believed to have not led to any enforcement actions and it’s unclear if the focus of the investigation was on Serruya or Defrancesco or both. The OSC would not comment on the status of the investigation for this publication but people familiar with the situation say it is closed.

According to an email sent by former Stikeman Elliott attorney Curtis Cusinato sent to Michael Serruya on July 26, 2018 titled ‘Accounts for Menchie’s Frozen Yogurt & Second Cup‘, attorney Cusinato was asking for $50,000 to be paid in legal fees and wanted these accounts cleaned up before he took over as Managing Partner of the Toronto office of Stikeman. Cusinato, who is Andy Defrancsco’s brother in law, told Michael in the email:

“How about as a thank you for bailing you guys out of jail you see tonit that our bills are paid from a year ago please! 🙂 or send some bath oils”

It’s unclear what other information about deal flow and trading the OSC gathered from Serruya during the interview or a review of his communication devices.

Andrew Rudensky worked as a retail broker at Canadian brokerage house Richardson GMP Limited where Defrancesco was his client. Rudensky ran into some trouble the IIROC that involved an enforcement action with fines of $56,923 and he was suspended as a registered rep for two years according to a statement from the Canadian regulator IIROC on July 30, 2018. After the dust up it is believed he went to work for Defrancesco at his investment firm Delavaco.

Defrancesco’s South Florida Delavaco office

Last month Second Cup announced that they were amending their agreement with the Serruyas which allowed them to nominate people to the board based on how much stock they owned. The Serruyas have been invested via 4 holding companies. The amendment took away the Serruya’s option to nominate two board members.

SEC looking at New Names in Barry Honig Pump and Dump Scheme: $MGTI $MBVXQ

The Securities and Exchange Commission is trying to force one of the remaining defendants in the Barry Honig pump and dump scheme to turn over communication or documents that could show others role in the long running scheme. Yesterday the regulator filed a motion to compel against MGT Capital CEO Robert Ladd who refused SEC enforcement attorney Nancy Brown’s demand for documents that relate to Harvey Kesner, Honig’s long time SEC transaction lawyer, and others who invested in the company or are suspected of promoting the company.

Ladd’s attorney Randall Lee of Cooley LLP said Ladd objects to having to produced continued communication with the requested individuals after the SEC filed their initial complaint on September 7, 2018 citing those documents would likely be attorney client privilege. Attorney Harvey Kesner was not named in the original subpoena sent to MGT Capital in September 2016 that sought documents showing Barry Honig and his team were trading as a group of undisclosed affiliates. The news of the SEC investigation into Team Honig was first reported by this journalist at trade publication Growth Capitalist. Kesner has made statements in other court filings and in press reports that he does not think he is under SEC investigation. The new court filing could show otherwise.

The motion also the states the SEC has already collected documents from over 100 individuals and corporations, a move that shows how far reaching the investigation has been. Additionally, the SEC wrote in a letter to Judge Ramos on August 8th that they are currently investigating conduct that is distinct from and occurred after the SEC filed their amended complaint in March 2019. This means more charges could be coming.

Individuals the SEC is currently seeking information about as discovery in the pump and dump ring include:

Tara Guarneri-Ferrara – a partner level attorney that worked with Harvey Kesner at New York-based Sichenzia Ross Ference LLP

Avital Even-Shoshan – an attorney who worked for Harvey Kesner at New York-based Sichenzia Ross Ference LLP. Kesner listed Avital as the managing director of the transfer agent he is believed to have funded called Equity Stock Transfer. She also goes by Avital Perlman.

Jay Kaplowitz – a partner at Sichenzia Ross Ference LLP who was MGT Capital’s deal transaction lawyer. MGT switched counsel after the SEC subpoena was delivered.

Richard Abbe and Josh Silverman of Iroquois Capital – Iroquois was an initial investor in MGT Capital and is believed to have held investments in the company during the alleged stock pump. Iroquois and Josh Silverman were named in the original SEC subpoena to MGT Capital.

Yova Roth, Richard Allison, and George Antonopolous of Hudson Bay Capital – Hudson Bay invested in MGT Capital and is alleged to be part of a scheme to force MabVax to reverse merge into a company Barry Honig controlled.

Drew Ciccarelli – a stock promoter that owned Global Marketing Media who has allegedly been part of paid promotions for Team Honig for years. He owned multiple stock promotion websites (such as and TSX Ventures LLC) and an investor email database business that was allegedly sold to another promoter Adam Garcia of after he saw too many of his clients get charged by the SEC or DOJ, according to a person familiar with Ciccarelli. and TSX Ventures LLC are named in the discovery request by the SEC. @alldaytrader is Ciccarelli’s current twitter account.

There are additional names the SEC wants info on that Ladd says he likely doesn’t know which you can see in this document. Ladd’s attorney argues that the SEC is actually abusing discovery with these request because they fall outside a statue of limitations.

I was first to report defendants in the Honig Pump and Dump case along with possible others are part of a microcap criminal investigation by the Northern California Department of Justice. Honig recently settled with the SEC and agreed to a bar on penny stock investing. It’s believed he is cooperating with the SEC now as they battle the remaining defendants. Honig could also likely turn evidence over on any of the people named in the recent SEC discovery request.

Update: 6.20.10 8:30pm: After my story ran Ladd’s attorney wrote Judge Ramos a letter calling out the SEC for more questionable tactics. While this publication agrees the SEC moves are questionable as a matter of law at least the SEC is making a rare move to inform the public about others that could be involved in the securities fraud case.

Editors Note: Harvey Kesner has sued me and Bill Alpert at Barron’s for our individual reporting on Kesner’s possible role in the Honig securities fraud scheme in Southern Florida district court. I will be fighting the suit pro se; meaning I will be representing myself. I firmly believe all of my reporting on Kesner is stated with accurate facts or opinion. I believe Kesner’s move is another attempt to get access to my sourcing in the government investigation of his clients or him.

Andy Defrancesco Secret Deals-Promoter Payoffs, Verano Shares pledged : $APHA $SOLCF

Cannabis company Sol Global Investments ($ $SOLCF) posted positive net income in their year end financials but failed to discloses key details about one of their most valuable assets which is their shares of Verano. The Toronto based company is run by controversial investor Andy Defrancesco in the role of Chairman and Chief Investment Officer and his side kick a former Florida lobbyist, Brady Cobb, who serves as CEO.

On July 8th Sol Global announced it had received a $37.5 million U.S. dollars private placement investment made as a senior secured loan with 6% interest and a two year pay back. At the time of the announcement the stock was trading at $1.55. Over the past six months the stock has been on a decline after a one day high of $3.02 on March 21st. Sol Global said in filing with the Canadian Stock Exchange that the transaction was arms length, which means Andy and insiders of the company didn’t personally loan the money to company. There was a lot of market speculation on who would give a fledgling cannabis company who was short on cash that much money. According to a person familiar with the company who had direct knowledge of the investment the money came with a catch. Defrancesco had to pledge the Verano shares as secured collateral if Sol Global can’t payback the loan in two years. The firm lending the money is suspected to be a Canada based firm and there is market chatter that MM Capital is the lender.

On October 23 2018 Sol Global made a $88 million investment in Verano, a private cannabis company, in deal that was intended for Verano to buy Sol Global’s Florida medical cannabis farm called 3 Boys Farms. According to the Florida office of Medical Marijuana, 3 Boys Farm had not even secured its full license to sell and distribute the cannabis at the time of the announcement. That deal fell apart after Defrancesco was hit with negative press coverage in December challenging his business ethics and undisclosed insider dealings. Then on March 11, 2019, Harvest Health & Recreation Inc.(CSE: HARV) announced its intention to acquire Verano in an all share transaction for a purchase price approximating USD$850,000,000 which was based on a Harvest share price of CAD$8.79 per share. Sol Global’s class B private shares in Verano have a good chance of becoming very valuable once the Harvest deal closed. The company told investors they thought the book value per share of their Verano investment was $4 CAD.

In a series of text messages I obtained between Andy and an investor in Verano/Harvest Andy was worried the men running Harvest and Verano were going to try to cut him out of the merger shares. The texts show Andy was asked to stop tweeting that he had a role in the Harvest/Verano deal. In fact the Harvest/Verano leadership wasn’t communicating with him and wouldn’t let him issue a press release clarifying for investors that 3 Boys Farm couldn’t be sold to Verano now; because Florida’s medical marijuana rules only allow a company to own one cannabis farm license and Harvest already owned one. Eventually the investor helped Andy get permission to communicate how Sol Global was effected by the deal.

Sol Global’s year end 2018 income was negative $19,343,230 million. For the year ending March 31, 2019 Sol Global reported a positive net income of $71,245,897 million U.S. dollars, which was a significant improvement.The largest bucket of revenue came from Sol’s gain on the sale of the LatAM assets to Aphria with a whopping earn out of $150,616,833 million U.S. Dollars.

Defrancesco was caught up in controversy this winter when a short seller report detailed how he made undisclosed millions off leading the sale of LatAM cannabis licenses to Aphria ($APHA) for inflated values. He is being personally sued for securities fraud in the Southern District of New York in a class action lawsuit filed by main street shareholders of Aphria. Court filings show Andy has been avoiding service of the Aphria lawsuit at his Miami home and Florida office. Defrancesco is currently working in the U.S. off a green card and hasn’t traveled outside the US recently over concerns he would not be let back in. Sol Global’s year end financials also failed to disclose it’s chairman and chief investing officer is subject to a lawsuit that alleges he used his influence of Sol Global to make the questionable deal where Aphria paid around $200 million for the LatAM cannabis assets. A few months after the short seller report came out Aphria wrote down one of the assets in the report by $50 million. The stock tumbled on the news.

The Short Seller report written by Nate Anderson of Hindenburg Research and Gabe Grego Quintessential Capital Management caused Defrancesco to start personal attacks on the fund managers. Grego’s website was even hit was a DDOS attack causing it to crash. Defrancesco decided he need a black ops Public Relationship group to go to work drumming up counter press reports. That firm is called AWM Group. In their recent year end financials Sol Global admits it spent $3.6 million CAD on PR and consulting to “counter fraudulent short seller reports”. There were no lawsuits filed accusing the short sellers of fraud by the company and Aphria did not offer a point by point rebuttal to the report as publicly promised. Additionally, Defrancesco was working behind the scenes to get a cannabis analyst and a cannabis twitter stock jockey to write favorable coverage of Aphria and negative coverage on individuals who negatively reported on Defrancesco or companies he is involved in.

Twitter stock trader, that goes by the name Johnny Lambo, met with Defrancesco on King street in Toronto. According to how Lambo tells it Defrancesco wined and dinned him and offered to give him early insight into the company if he tweeted favorable news on Andy’s investment. When Lambo was out one night with another Bay street market player, interviewed by this reporter, Lambo said “Defrancesco also has this guy at Grizzle do coverage his way.” Lambo’s statement about Grizzle was made in justification of why he’s backing Defrancesco. His twitter handle is @lambojohnny and his real name is John Mastromattei. Lambo also told the Bay street market player he was given direction to tweet disparaging or fake news about this reporter.

Grizzle is a Canada based research firm that publishes reports on Tech and Cannabis with the mantra of “The language of new money”. The head of research is a man named Scott Willis who claims he is a certified financial analyst. Willis ran reports naming Aphria’s Vic Neufeld as the most trusted CEO. He published a multi-page report on November 1st 2018 giving Aphria a $200 price target and an individualized review of the LatAM assets with harvest production estimates and construction cost per gram. Grizzle immediately called the Hindenburg report a hit piece and tried to justify the Aphria share price the day after the short seller report became public.

The Grizzle stock price estimate helped prop up Aphria stock while Sol Global was selling their Aphria shares received from the LatAm sale. Sol Global booked profits in the triple digit millions off Aphria stock sales. The management review of Aphria’s CEO Vic Neufeld as a trusted public company executive was designed to counter a previous negative report about Neufeld’s role in a company Aphria was going to buy called Nuuvera. Nuuvera was another Defrancesco insider deal. A footnote to the report states Grizzle employees own Aphria shares. But no where in the Grizzle reports does it state Scott Willis was getting paid by Defrancesco or one of his many companies he controls to write the reports. Vic Neufeld was eventually removed from Aphria.

Andy Defrancesco celebrating with Vic Neufeld December 2017

Grizzle had also agreed to center their coverage on Aphria and turned down at least one other public cannabis company, according to an email sent by Scott Willis and seen by this reporter. Willis met the CEO of the company during a marijuana investor conference. When the CEO had a one on one sit down with Willis asking him if Grizzle could also cover his company the CEO was surprised by Scott’s demand that he get 50,000 shares of the company, according to an interview with this reporter. The 50,000 shares to pay for research was also written in an email between Willis and the CEO and seen by this reporter. Shortly after the meeting Willis wrote the CEO back saying he was going to have to pass on covering his company.

Willis wrote in August 2018, “I talked with my partner about your firm after our meeting and he agrees you guys have some great things going, but we will have to circle back with you in a month or two. We are currently working on a mandate for one of the big 3 producers..” The big 3 producer is believed to Aphria according to people familiar with the arrangement. The CEO says he never heard from Willis after that email and Grizzle never covered his company.

Companies can pay for research as long as the payment is disclosed by the company. In the U.S. SEC rules say a person writing and publishing a stock research report would have to disclose they were paid to write the report as a promoter. Grizzle adds a disclaimer to their website, that can be seen around the world, that their reports are only intended for Canada residents. It’s unclear if Scott Willis is a U.S. or Canadian resident.

Request for comment about the alleged Grizzle kickback sent to Andy’s Quinn Emanuel attorney was not returned for comment.

Yesterday David Milstead at the Globe & Mail was first to report that Defrancesco has hired a white collar criminal lawyer from big law Quinn Emanuel. He is a 36-year old Harvard grad named Alex Spiro who formerly worked in the Manhattan prosecutors office. Spiro admitted in the Globe & Mail story that he is working with the SEC on behalf of Defrancesco to respond to a recent subpoena in another non-cannabis company, Cool Holdings ($AWSM), that was an alleged pump and dump run by Barry Honig with the help of Defrancesco. I previous reported on how Defrancesco and Honig worked with broker dealer Laidlaw to allegedly off load $AWSM shares to Laidlaw’s main street clients.

I asked attorney Spiro today if he will also be representing Defrancesco in the Aphria lawsuit and he responded yes so it looks like Andy has finally stopped running from service.

Since Sol Global’s positive year end results have come out the stock has not traded above $2. The company will hold an earnings call on August 8th at 4pm to answer investor questions. The dial in number is: U.S. Toll-Free Number: (888) 390 0546

Update 8-8-19: Sol Global CEO Brady Cobb announced on the earnings call that there will changes to the company board in the coming weeks. Andy Defrancesco is Chairman of the board.